Description of liquid biopsy applied in HNC studies highlighted in this review
Circulating biomarkers | Biofluid types | HNC category | Molecular assays | Detection/isolation methods | References |
---|---|---|---|---|---|
cfDNA | Plasma | HNSCC | CNAs | NGS | [11, 12] |
HNSCC | Somatic mutations | ddPCR | [14] | ||
OPSCC | Somatic mutations | NGS | [16] | ||
HNSCC | Quantification | Qubit fluorescence | [23] | ||
OPC | DNA methylation | Q-MSP | [35] | ||
HNSCC | DNA methylation | qPCR; quasi-digital PCR | [36, 37] | ||
OPSCC | DNA methylation | ddPCR | [38] | ||
Plasma and saliva | OSCC | Somatic mutations | NGS | [21] | |
cfmtDNA | Plasma | HNSCC | Quantification | qPCR | [29] |
cfHPVDNA | Plasma | OPSCC | Quantification | ddPCR | [39, 41, 42] |
qPCR | [40] | ||||
miRNAs | Plasma | Tongue SCC | Expression | PCR arrays | [49] |
LSCC | Expression | ddPCR; qRT-PCR | [50, 55] | ||
OSCC | Expression | NGS | [51] | ||
HNSCC | Expression | qRT-PCR | [54, 57] | ||
HNSCC | Expression | NGS | [59] | ||
Serum | OSCC | Expression | qRT-PCR | [52] | |
LSCC | Expression | PCR arrays | [53] | ||
HNSCC | Expression | qRT-PCR | [56] | ||
LSCC | Expression | qRT-PCR | [58] | ||
Saliva | OSCC | Expression | qRT-PCR; PCR arrays | [60, 61] | |
HNSCC | Expression | qRT-PCR; PCR arrays | [62] | ||
qRT-PCR; NGS | [63] | ||||
PCR arrays | [64] | ||||
Serum and saliva | Salivary gland tumors | Expression | qRT-PCR | [65] | |
lncRNAs | Plasma | HNSCC | Expression | PCR arrays; NGS | [66] |
OSCC | Expression | qRT-PCR | [67] | ||
HNC | Expression | Semiquantitative PCR | [68] | ||
HNSCC | Expression | qRT-PCR | [69] | ||
CTCs | BM and bloodstream | HNSCC | Detection and counting | Immunocytochemistry and fluorescence microscopy | [72, 81] |
Detection | RT-PCR | [73, 79] | |||
Bloodstream | HNSCC and OSCC | Detection and counting | Ficoll-Hypaque, dextran sedimentation and immunocytochemistry | [74, 76–78] | |
HNSCC | Detection and counting | CellSearch® | [75, 82] | ||
LAOC | Detection and counting | RosetteSepTM technique and immunocytochemistry | [83] | ||
rHNSCC | Detection and counting | EPISPOT, FCM and CellSearch® | [84] | ||
HNSCC | Detection and counting | SERS | [85] | ||
EVs | Plasma | HNSCC | Quantification; characterization | Size-exclusion chromatography; FCM | [93, 94, 96, 99] |
OSCC | Cargo analysis (miRNAs profile) | Commercial kit; qRT-PCR | [100] | ||
HNSCC | Cargo analysis (miRNAs profile) | Commercial kit; qRT-PCR | [101] | ||
Tongue SCC | Cargo analysis (protein profile) | Centrifugation and size-exclusion chromatography; isobaric labelling (iTRAQ) and two-dimensional high-performance liquid chromatography followed by tandem mass spectrometry | [104] | ||
Saliva | OSCC | Cargo analysis (miRNAs profile) | Centrifugation; qRT-PCR array | [102] | |
Commercial kit; qRT-PCR array | [103] | ||||
Cargo analysis (protein profile) | Ultracentrifugation; SWATH_MS (Sequential Window Acquisition of all Theoretical Mass Spectra) | [105] |